Impact of previous percutaneous coronary intervention on postoperative outcomes of coronary artery bypass grafting

Year 2016, Volume: 2 Issue: 3, 170 - 176, 04.11.2016

Mihriban Yalcin , Derih Ay , Tamer Turk , Senol Yavuz , Ahmet Fatih Ozyazicioglu

https://doi.org/10.18621/eurj.2016.5000190033

Cited By: 2

Abstract

Objective. The widespread use of percutaneous coronary intervention (PCI) has resulted in an increasing number of patients who have undergone prior PCI being referred for coronary artery bypass grafting (CABG). The aim of this study was to determine the association between previous PCI and early and midterm outcomes after CABG. Methods. A total of 54 patients undergoing elective CABG (group 1) between January 2008 and January 2009 were compared to 46 patients who had a history of bare metal stent implantation before CABG (group 2). Mean follow-up was 12 months. Results. The average time interval to CABG following initial PCI was 18.5 months. There was no significant difference in demographic features and risk factors between the two groups (p>0.05). There were also no significant differences in intraoperative and postoperative data, and no significant differences for in-hospital mortality, cardiac mortality and total mortality and in the number of rehospitalizations for cardiac or for all-cause reasons (p>0.05). Conclusion. In this study, previous PCI did not significantly influence the outcomes of CABG in a 12-month follow-up period. 

Keywords

Coronary artery bypass grafting, percutaneous coronary intervention, coronary artery disease, postoperative outcomes

References

• Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171.
• Barakate MS, Hemli JM, Hughes CF, Bannon PG, Horton MD. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience. Eur J Cardiothorac Surg 2003;23:179-86.
• Kalaycioglu S, Sinci V, Oktar L. Coronary artery bypass grafting (CABG) after successful percutaneous transluminal coronary angioplasty (PTCA): is PTCA a risk for CABG? Int Surg 1998;83:190-3.
• Yock CA, Yock PG. The drug-eluting stent information gap. Am Heart Hosp J 2004;2:21-5.
• Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 2004;110:1226-30.
• Mercado N, Wijns W, Serruys PW, Sigwart U, Flatter MD, Stables RH, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005;130:512-9.
• Johnson RG, Sirois C, Thurer RL, Sellke FW, Cohn WE, Kuntz RE, et al. Predictors of CABG within one year of successful PTCA: a retrospective, case-control study. Ann Thorac Surg 1997;64:3-7.
• Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-40.
• Holmes DR Jr, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002;106:1243-50.
• Gaudino M, Cellini C, Pragliola C, Trani C, Burzotta F, Schiavoni G, et al. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation 2005;112(Suppl):I265-9.
• Muhlestein JB. Endothelial dysfunction associated with drug-eluting stents what, where, when, and how? J Am Coll Cardiol 2008;51:2139-40.
• Stone PH, Coskun AU, Yeghiazarians Y, Kinlay S, Popma JJ, Kuntz RE, et al. Prediction of sites of coronary atherosclerosis progression: in vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior. Curr Opin Cardiol 2003;18:458-70.
• Massoudy P, Thielmann M, Lehmann N, Marr A, Kleikamp G, Maleszka A, et al. Impact of prior percutaneous intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. J Thorac Cardiovasc Surg 2009;137:840-5.
• Tran HA, Barnett SD, Hunt SL, Chon A, Ad N. The effect of previous coronary artery stenting on short- and intermediate-term outcome after surgical revascularization in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2009;138:316-23.
• Bonaros N, Hennerbichler D, Friedrich G, Kocher A, Pachinger O, Laufer G, et al. Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2009;137:846-52.
• Hassan A, Buth KJ, Baskett RJ, Ali IS, Maitland A, Sullivan JA, et al. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J 2005;150:1026-31.
• Thielmann M, Leyh R, Massoudy P, Neuhauser M, Aleksic I, Kamler M, et al. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery. Circulation 2006;114(1 Suppl):I441-7.
• Thielmann M, Neuhäuser M, Knipp S, Kottenberg-Assenmacher E, Marr A, Pizanis N, et al. Prognostic impact of previous percutaneous coronary intervention in patient with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007;134:470-6.
• Rao C, De Lisle R, Chikwe J, Pepper J, Skapinakis P, Aziz O, et al. Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study. Ann Thorac Surg 2008;85:501-7.
• Chocron S, Baillot R, Roucleau JL, Warnica WJ, Block P, Johnstone D, et al.; IMAGINE Investigators. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study. Eur Heart J 2008;29:673-9.
• Mannacio V, Di Tommaso L, De Amicis V, Luchetti V, Pepino P, Musumeci F, et al. Previous percutaneous coronary interventions increase mortality and morbidity after coronary surgery. Ann Thorac Surg 2012;93:1956-62.
• Songur MC, Ozyalcin S, Ozen A, Simsek E, Kervan U, Tasoglu I, et al. Does really previous stenting affect graft patency following CABG? A 5 year follow-up: The effect of PCI on graft survival. Heart Vessels 2016;31:457-64.
• Gaszewska-Zurek E, Zurek P, Kazmierski M, Kargul T, Duraj P, Jasinski M, et al. Coronary artery bypass grafting in patients with relatively recent previous stent implantation: three years follow-up results. Cardiol J 2009;16:312-6.
• Velicki L, Cemerlic-Adjic N, Panic G, Jung R, Redzeg A, Nicin S. CABG mortality is not influenced by prior PCI in low risk patients. J Card Surg 2013;28:353-8.
• Yap CH, Yan BP, Akowuah E, Dinh DT, Smith JA, Shardey G, et al. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv 2009;2:758-64.
• van den Brule JM, Noyez L and Verheugt FW. Risk of coronary surgery for hospital and early morbidity and mortality after initially successful percutaneous intervention. Interact Cardiovasc Thorac Surg 2005;4:96-100.
• Ueki C, Sakaguchi G, Akimoto T Shintani T, Ohashi Y, Sato H. Influence of previous percutaneous coronary intervention on clinical outcome of coronary artery bypass grafting: a meta-analysis of comparative studies. Interact Cardiovasc Thorac Surg. 2015;20:531-7.
• Taguchi I, Yoneda S, Abe S, Toyoda S, Nasuno T, Nishino S, et al. The late-phase inflammatory response after drug-eluting stent implantation. Heart Vessels 2014;29:213-9.
• Alagem-Shafir M, Kivovich E, Tzchori I, Lanir N, Falah M, Flugelman MY. The formation of an anti-restenotic/anti-thrombotic surface by immobilization of nitric oxide synthase on a metallic carrier. Acta Biomater 2014;10:2304-12.